Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Women's interest in vaginal microbicides.

J E Darroch1, J J Frost

  • 1Alan Guttmacher Institute (AGI), New York, USA.

Family Planning Perspectives
|February 25, 1999
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pain activation of human supraspinal opioid pathways as demonstrated by [11C]-carfentanil and positron emission tomography (PET).

Pain·2002
Same author

Adolescent pregnancy trends and demographics.

Current women's health reports·2002
Same author

PET imaging of brain acetylcholinesterase using [11C]CP-126,998, a brain selective enzyme inhibitor.

Synapse (New York, N.Y.)·2002
Same authorSame journal

Differences in teenage pregnancy rates among five developed countries: the roles of sexual activity and contraceptive use.

Family planning perspectives·2002
Same authorSame journal

Socioeconomic disadvantage and adolescent women's sexual and reproductive behavior: the case of five developed countries.

Family planning perspectives·2002
Same author

PET imaging of the opioid receptor: the early years.

Nuclear medicine and biology·2001

Millions of women are interested in using vaginal microbicides for sexually transmitted disease (STD) prevention. Research indicates a significant demand for these new STD prevention methods, particularly among women worried about infections.

Area of Science:

  • Public Health
  • Infectious Diseases
  • Women's Health

Background:

  • An estimated 15 million new sexually transmitted diseases (STDs), including HIV, occur annually in the U.S.
  • Women face heightened biological and social susceptibility to STDs, compounded by limited prevention options.

Purpose of the Study:

  • To assess women's concerns regarding STDs and their interest in vaginal microbicides.
  • To identify characteristics influencing women's preferences for microbicide products.
  • To estimate the number of potential users for microbicidal products in the U.S.

Main Methods:

  • Telephone interviews were conducted with a nationally representative sample of 1,000 women aged 18-44 in the continental U.S.
  • Participants had engaged in sexual activity with a male partner within the past 12 months.
Keywords:
AmericasContraceptionContraceptive MethodsContraceptive UsageDeveloped CountriesDiseasesEconomic FactorsFamily PlanningHiv Infections--prevention and controlInfectionsMethod Acceptability--womenNorth AmericaNorthern AmericaReproductive Tract InfectionsResearch And DevelopmentResearch MethodologyResearch ReportSampling StudiesSexually Transmitted Diseases--prevention and controlSexually Transmitted Diseases--womenStudiesSurveysTechnologyUnited StatesVaginal SpermicidesViral DiseasesWomen

Related Experiment Videos

  • Analysis focused on levels and predictors of STD worry, microbicide interest, and product preferences.

    • Main Results:

    • Approximately 21.3 million U.S. women expressed potential interest in using vaginal microbicides.
    • Up to 6.0 million women, particularly those worried about STDs, showed strong interest in current microbicide use.
    • High interest was noted among unmarried, lower-income, less-educated, Black, and Hispanic women, and those with specific sexual health behaviors.

    Conclusions:

    • A substantial portion of U.S. women are concerned about STDs and receptive to using vaginal microbicides.
    • The findings underscore the need to accelerate the development, testing, and marketing of these novel prevention tools.